ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, TYMS, THBS1, FOSL1, CLDN4, FOSB, CD38, TLR2]
GO:0009435;NAD biosynthetic process;11.0;0.7980440201809971;0.8314509624201607;9.500690880982237;2002.0309936558642;5.825829909099042;0.06700617564674446;0.730362164809784;[PTGS2, ENO2, HK3, KYNU, BPGM, KMO, PARP9]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, EGFR, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, RIPK2, CD40LG, MDFIC, PKN1, MAP3K11]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA1, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, PIK3C3, MET, HBEGF, PDGFA, PIK3R3, EGFR, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[NOD2, TNF, RIPK2, TRIB1, MAP3K11]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, AIM2, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, KDR, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ITGA5, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, RRAS, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, IGF1, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1, MAP3K11]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, ITGAV, CD36, FCGR1A, FCGR1B]
GO:0030823;regulation of cGMP metabolic process;9.0;0.7586651285174919;0.775573189439035;9.392135474427892;212.55514157362143;6.444869117505266;0.00711402930126111;0.7258315315665724;[FZD2, PDE5A, GUCA1C, THBS1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, PKIA, SNAI2, PKIG, EZH2, BTG2, CDKN1B, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, STAT1, CDKN2A, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, CSF2, GMNN, TNF, DACH1, TNFRSF4, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, SP3, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, NOG, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, RBL1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, AKR1C3, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[CDKN1B, PAK1, PSRC1, FES, MET]
GO:0007143;female meiotic nuclear division;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;65.96656019186406;7.069023426578259;0.0022078414035718876;0.7124295520356204;[PPP2R1A, TRIP13, MASTL, EREG]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, CSF3, FES, NTF3, STAP1, HCLS1, TEK]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0045410;positive regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.3044735649636;7.8311634786251565;0.02792341990494083;0.7754860644832351;[TLR1, IL1B, PTAFR, TLR6, EREG]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0033091;positive regulation of immature T cell proliferation;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;650.2950849628645;8.390779266560578;0.0217647912661268;0.8443458537639685;[RIPK2, IL1B]
GO:0042700;luteinizing hormone signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;8.67846133901236;9.028936615729279E-4;0.7669372290569613;[LHCGR, EREG]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[DLC1, ARHGAP6, THBS1]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, KDR, AKT1, PDGFRB, MED1, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, VIL1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, HDAC2, THBS1, EGFR, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4, RPS6KB1]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[SPARC, CDKN1B, PRL, PTPRK, BRCA2, PHB2, TNF, DUSP10, MEN1, MED1, MEF2C, EREG, TGFBR3, CEACAM1, SFRP2, NLRC3, GATA3, THBS1, CCL2, SFN, TGFB2, TGFB1, CAV2, VDR, STAT1, CAV1, NR2F2, SULF1, CDK6, SNAI2]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, CSTA, ANXA1, EPB42, FN1, BGN, F13A1, THBS1, DCN, COL3A1, SPOCK2, SPOCK3, TGM2]
GO:0034976;response to endoplasmic reticulum stress;4.0;0.6799073451904818;0.5899536725952409;8.284789505791027;28.997869804256865;4.300610075748959;9.705326059599744E-4;0.4699333992726228;[TRIM25, TMX1, TLN1, ATF3, TXNDC5, JUN, WFS1, TNFRSF10B, EIF2AK2, EIF2S1, BCL2, SRPX, FKBP14, PPP1R15A, CEBPB, DERL3, FAM129A, THBS1, CCL2, PML, PSMC6, PSMC2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, MET, HBEGF, ENG, PDGFA, GATA3, THBS1, EGFR, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, AKR1C3, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, ICAM1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, BST2, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CASP1, CCR7, CD36, CHUK, RIPK2, RHOC, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0002581;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;55.710237364246;8.67846133901236;0.0018645715086227877;0.7669372290569613;[HLA-DOA, HLA-DOB, THBS1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, IGF1, SELP, TF, CD9, PF4]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, MED1, KIT, LMO2, CTSH, GAS2L1, GATA1, CTSS, CTSB]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[CSF2, IL5RA, TNF, FGF5, KDR, TNFSF11, MAP3K8, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, IGF1, PTK2, NFKB1, LAT, MAP3K11, LRRK2, CTSH, ITGAV, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, MET, HBEGF, CAMK2D, NOD2, IL2RG, EGFR, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RA, IL2RB, TEK]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, HDAC2, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, KIF14, TGFA, PDGFA, AURKB, FGF5, LBH, RACGAP1, PDGFD, NUP62, PDGFC, ECT2, SVIL, TGFB2, TGFB1, PRKCE, TAS2R13, OSM, KIF23, CDC6, PPBP, CIT, EREG, BTC, IL1A, TAL1, IL1B, KIF20B]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, RIPK2, EBI3, IL18, CD3E, HLA-E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0010757;negative regulation of plasminogen activation;10.0;1.0;0.9152410118609203;9.628524252492122;820.5340776865997;7.9853141584524145;0.027462537147443688;0.8236103492792612;[CTSZ, SERPINE1, THBS1]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, PSMB8, HLA-DPB1, PF4, CSF3, CSF3R, CSF2, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, TNFRSF4, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF9, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF18, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RA, IL2RB, PTPN6, IL1RN, IFITM1, IFI35, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, IL15RA, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, BST2, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, CASP1, MMP1, MMP2, IRAK3, MMP9, DCN, AIM2, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, S1PR1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, EGFR, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, FOSL2, BTC, CCNA2, CDK6, CDK4, NDUFS4]
GO:1990668;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;65.8060249050737;7.9853141584524145;0.0022024684319953925;0.7592887026755414;[TAP1]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0010754;negative regulation of cGMP-mediated signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;9.777073627680469;0.008005804360164796;0.875;[THBS1]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[CDKN1A, PID1, ITGAM, ITGB2, TNF, CLU, ICAM1, AKT1, CD36, CD177, PDGFRB, EDN1, PRKCD, DNM2, IFNG, IL1B, AGTR1, TLR6, TLR4, FPR2, PTGS2, THBS1, AIF1, EGFR, GNAI2, KLRK1, SNCA, TGFB1, AGXT2, AKR1C3, MAPK14, KLF4, NOX4, F2RL1, PTX3]
GO:0010751;negative regulation of nitric oxide mediated signal transduction;8.0;1.0;0.875;9.628524252492122;239.1998693179246;8.67846133901236;0.008005804360164796;0.8188169164668168;[THBS1]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, NR1H4, TLR8, TLR7, PIK3C3, MYD88, HAVCR2]
GO:1901253;negative regulation of intracellular transport of viral material;8.0;1.0;0.875;9.628524252492122;128.34822619036495;9.083926447120524;0.004295699624687222;0.839552420951524;[BST2]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, HTRA1, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, ADAM8, TIMP1, LCP1, A2M, ELANE]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, EGFR, GRAP2, KDR, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, RIPK2, BTK, TLR8, TLR7, TLR4, CARD11, BIRC2, BIRC3, LY96, NLRC3, RELB, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0002224;toll-like receptor signaling pathway;11.0;0.6763753087927167;0.7706166067260205;9.040737587590003;409.6592600291497;5.311165509025885;0.01371092676377766;0.7040422034557006;[ITGAM, ITGB2, CTSS, CD36, HAVCR2, CHUK, RIPK2, PRKCE, CD180, IRAK3, TLR1, BTK, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, S100A9, S100A8, TLR2, COLEC12, UNC93B1, LY96, HSPD1, S100A14, CD14, CD300LF, NR1H4, NFKBIA, TNIP3, MYD88]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, CASP1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, EGFR, KCNJ2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, ADARB1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKCE, PRKCD, PRKAR1B, ATF3, PRKDC, FPR1, PDGFA, FPR2, THY1, SLC30A10, IQGAP3, GATA1, PRKCZ, SAMSN1, C3, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FN1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, PKIA, NOX4, PKIG, NOX1, EZH2, CDKN1A, CDKN1B, LRRC4, TIMP2, PBK, TIMP3, HAVCR2, DUSP2, GPR37, DUSP3, DUSP1, RIPK2, FCRL3, BGN, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, LRRC19, FAM129A, PTGS2, EGFR, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CDKN2A, CARD9, GTF2H1, ELP4, CENPE, PKN1, CDKN3, CSF3, CCNT2, CSF2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, MEN1, IFNA14, MAP2K2, CISH, IFNA16, IGFBP3, F2R, CDC25C, CDC25A, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, BLM, TNFRSF11A, PKMYT1, FOXO1, SOCS2, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, DAB2, COPS5, PTPRC, CDK6, CDK4, CDK1, BCL2, PLXNB2, CSPG4, LAT, MAP3K11, LRRK2, ITGB3, ITGB2, TREM2, PTPN22, ARRB1, ARRB2, FOXM1, CYR61, HHEX, DUSP10, EMILIN1, ITGAV, TNFRSF18, XCL2, XCL1, LCP2, ITGA5, MET, CEBPA, HDAC2, TTK, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, KLF4, PML, RAD50, PTPN6, FCGR2B, PPIL4, IL1RN, CCNH, CCNF, CCNC, ICAM1, HERC5, TCL1A, EDNRB, PPP2R1A, CHEK2, KDR, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EREG, SFRP2, IL23A, TRIB1, EPHA3, EPHA2, TGFA, TWIST1, PIK3R5, PKHD1, RRAS, SLAMF1, CCR1, EGR1, GADD45B, LIF, IGF1, PTK2, BST1, MARCO, TPX2, ID1, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, CD40, IFNA2, KIF14, CD3E, IFNA8, RAC2, CCR7, CD36, MAP4K1, EDN1, SYK, IL15, STRADB, NOG, IL18, GP1BA, PARP9, CEACAM1, MDFIC, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, PODN, NLRP12, CD40LG, F2RL1, CAMK1, CD80, CCND2, IL6R, PDGFRB, PDGFRA, CD300A, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, FBLN1, ADRB2, RASGRP1, CCNB2, CCNB1, HRH4, STAP1, CLSPN, ECT2, FAM83D, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GNAQ, TNFAIP3, CKS1B, GHR, GRM5, LRRTM4, NUP62, MYOCD, PDE4D, PLAUR, IRAK3, AXIN2, MMP9, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, NDUFS4, CHI3L1, PDE5A, ZMYND11, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, CDKN1B, TIMP2, HAVCR2, GPR37, RIPK2, FCRL3, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, EGFR, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, CSF2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, MAP3K11, LRRK2, ITGB3, TREM2, PTPN22, ARRB1, ARRB2, CYR61, ITGAV, TNFRSF18, XCL2, XCL1, LCP2, ITGA5, MET, HDAC2, TTK, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, CCNC, ICAM1, TCL1A, EDNRB, CHEK2, KDR, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, GADD45B, LIF, IGF1, PTK2, MARCO, TPX2, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, KIF14, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, IL15, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, F2RL1, CAMK1, CD80, CCND2, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, CKS1B, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[NRP1, CSF2, SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, TNF, ICAM1, LGALS3, AKT1, ITGAV, GPX1, DAPK1, STRADB, IL1A, SFRP2, IL1B, ZMYND11, CX3CR1, YAP1, IFI6, THBS1, GATA1, CTNNA1, HMOX1, FYN, TNFRSF10B, IGF1, RPS6KB1, BCL2, SNAI2, PF4, BCL2L1]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[SERPINE1, SPINT2, ADARB1, MYLK, DPYSL3, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, CLDN7, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, TACR3, EMP2, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, EGFR, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PKN1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, CDK6, BCL2, PLXNB2, ITGB3, PIK3CD, PIK3C2A, CYR61, SYNE2, DUSP10, EMILIN1, ITGAV, ITGA4, TNFRSF18, XCL2, XCL1, ITGA5, MET, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4A, SEMA4B, TIE1, KLF4, IL1RN, IFITM1, SPARC, ICAM1, LGALS3, KDR, IL1R1, ACTN4, MIF, EREG, BTC, SFRP2, IL23A, PFN1, TRIB1, KIF20B, NBL1, EPHA2, TWIST1, RRAS, CCR1, TNFSF14, PPBP, IGF1, PTK2, BST2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, KIF14, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, NOG, GAB1, RHOC, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, CTNNA1, MPP1, CD74, IL33, PODN, DLC1, F2RL1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, CD300A, VCL, C5AR1, FBLN1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, FES, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA2, LAMA4, LAMA3, LEF1, THBS1, SPOCK2, SPOCK3, S1PR1, EGF, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, PRKCE, AKT1, THBS1, SLC8A1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, CDKN1B, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, KIF20B, PPP1R15A, CUL5, THBS1, APBB1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, CDKN2A, DHCR24, INHBA, PML, CDK6, FAP, JMY, CDKN3]
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;298.26786127592857;7.004484905440688;0.00998275689325772;0.7091290490632969;[GATA3, SULF1, THBS1, SULF2]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, FAM129A, THBS1, RXRA, CCL5, UPF3B, IL6, LIN28A, RPS6KB1, CDK4, BCL3, CD28, EIF3E, EIF3D]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, PIK3C2A, EGFR, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0043420;anthranilate metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;223.03738466346266;9.777073627680469;0.0074648605440717835;0.875;[KYNU]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, AURKA, NUP62, NUSAP1, DLGAP5, SH2B1, PDGFRB, RANBP2, RANBP1, CDT1, EDN1, TGFB1, EGF, UBE2C, IGF1, EREG, BTC, IL1A, ESPL1, IL1B, CD28]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, CD300A, STXBP2, GAB2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0097053;L-kynurenine catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;764.3846786597122;9.083926447120524;0.025583267293192123;0.8797934328124444;[KYNU]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, ARRB1, BRCA1, ARRB2, BMI1, CDC20, SKP2, RIPK2, MASTL, BIRC2, BIRC3, ADRB2, NOD2, ANAPC10, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1, UBE2S]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, BST2, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, SPP1, EDN1, DUSP1, CAD, NME1, NASP, RPS6KB1, CDK4]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[, PSMD3, NEDD4L, ADAMTS12, ANAPC10, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP1, USP9Y, PSMB8, PSMC6, PSMC2, RNF43, CUL5, UBR1, WFS1, CDK1, ARRB1, ARRB2, SCPEP1, DTL, BIRC2, UHRF1, HM13, VPS4B, ZNRF1, RNF24, GZMA, PML, CCNF, CDC20, CDC23, TRIM25, SKP2, CDC34, CTSZ, KIF14, CTSW, CTSS, CTSH, CTSB, RNF144B, DERL3, PCNP, RANBP2, RANBP1, FAP, NEDD4, MAD2L1, BUB1B, PTTG1, PSMD14, CCNB1, UBE2C, ISG15, UBE2S, TNFAIP3, RNF6, USP18, AURKB, PSMB10, AURKA, TBX21, CPVL]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, RHOC, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, AKR1C3, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, GNG7, CCL4, S1PR1, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, ZBP1, CHUK, SYK, DDX58, RIPK2, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, PRKDC, HSPD1, PLCG2, CD14, STAT1, NFKB1, NFKB2, MYD88]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, AGL, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, TXNDC5, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, ITGAV, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST2, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CD300A, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, IL2RA, CD28, HLA-DPB1, CD24]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, ICAM1, EDNRB, SESN3, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, CYBB, EREG, POR, ADCY9, RAB31, PRKAR1B, PRKDC, ABCB4, SLC30A10, FOXO1, BRIP1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, GGH, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, CDK4, FBN1, BTG2, CDKN1B, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, STAT1, SORBS1, TSHR, RPS6KB1, TEK]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, IGKV4-1, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, SYNJ1, IGLV2-23, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, IGLV3-19, COLEC12, LRP1, CD5L, TMPRSS2, IGHV3-48, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, IGKV1-5, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0032914;positive regulation of transforming growth factor beta1 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.62186638127122;7.9853141584524145;0.0028656868131042177;0.7592887026755414;[LUM, THBS1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, TNFRSF4, CHUK, TNFRSF18, TNFRSF1B, AIM2, LTA, LTB, BIRC2, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, STAT1, TNFSF12, TNFRSF9, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[AIF1]
GO:0002605;negative regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.710237364246;9.083926447120524;0.0018645715086227877;0.7876727335416686;[FCGR2B, THBS1]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:2001259;positive regulation of cation channel activity;9.0;0.7043150770688792;0.7483981637147287;9.126432308694886;526.0857391442704;5.75172193694532;0.017607616242732247;0.6903839525180965;[KCNE3, ADRB2, CTSS, JPH2, EHD3, PLCG2, CALM3, EPHB2, SHANK3]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, CSF2, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, NOG, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, KDR, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, RHOC, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:0045627;positive regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2605.164725512912;7.9853141584524145;0.08719251886688177;0.8709243021859774;[ANXA1, HLX, RIPK2, CD80, CCL19]
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;527.9279232538245;7.379178354882098;0.017669272487020958;0.7523715242355574;[MMP12, ZBP1, IRF7]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, CDC7, EGFR, EREG, CST3, DBF4, CDK2, CDK1, DNA2, E2F7, E2F8]
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;12.0;0.9326813400603323;0.9144609826203107;9.611429819132821;2972.107935112762;7.292166977892469;0.09947377786474029;0.8210420709600095;[NCF1, EGF, TGFA, EREG]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[THBS1, HSPD1, HSPA6, HSPE1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[CCNF, LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMB8, PSMC6, PSMC2, NUCB1, DSCC1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, PSMB10, LAMB2, LAMB1]
GO:0001961;positive regulation of cytokine-mediated signaling pathway;7.0;0.7192862368539868;0.710562483684194;8.965230035081857;244.22079422365863;5.948432231191374;0.008173850198220667;0.6551224661907153;[TXK, GFI1, TREM2, CASP1, CD300LF, ZBP1, CD74, MED1, EDN1, IL1R1, RIPK2, PARP9, MMP12, IRF7]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, TLR8, TLR7]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, COLEC12, IFNA4, IFNA7, IFNA14, IFNA16, DDX58, RIPK2, CAV1, IFNA2, CARD9, IRAK3, IFIT1, IFNA8, NFKBIA, IFIH1, IFNA21, IFNA10]
GO:2001027;negative regulation of endothelial cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;484.3135532944439;8.390779266560578;0.016209538774865105;0.8443458537639685;[CXCL13, THBS1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0034769;basement membrane disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;37.78527758723771;8.67846133901236;0.0012646392363027793;0.7669372290569613;[CTSS]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[IFITM1, IFIT1, TNF, OASL, CCL5, RSAD2, EIF2AK2, ISG15, BST2, PLSCR1, SLPI, OAS1, OAS3, APOBEC3A, LTF]
GO:0019805;quinolinate biosynthetic process;8.0;1.0;0.875;9.628524252492122;691.6482702327052;8.67846133901236;0.023148845161657855;0.8188169164668168;[KYNU, KMO]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[CSF3, HMGB2, MPL, TNF, ETS1, CA2, TNFSF11, HOXA5, MED1, FOS, IFNG, IL23A, TAL1, HCLS1, TRIB1, LEF1, GATA1, INPP5D, NCKAP1L, CCR1, CD74, JUN, JAG1, STAT1, LIF, ISG15, INHBA, TMEM64, MAPK14, POU4F1, CD4, FES, ACIN1, EVI2B, PF4, IL17A]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, PSTPIP1, HCLS1, WASF3]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[ZBP1, USP18, MMP12, IRF7, PTPN6]
GO:0046967;cytosol to ER transport;5.0;1.0;0.7902410118609202;9.628524252492122;33.20429938101479;9.083926447120524;0.0011113180183532213;0.7547934328124444;[TAP1]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNA5, IFNA4, IFNA7, SP100, IFITM1, IFNA2, IFI6, IFI35, SAMHD1, IFIT1, IFNA8, IFIT3, IFIT2, OASL, IFNA21, EGR1, IFNA14, RSAD2, IFNA16, STAT1, MX2, HLA-B, HLA-C, ISG15, HLA-A, HLA-F, HLA-G, PSMB8, HLA-E, BST2, IFI27, OAS1, OAS3, IRF7, IRF8, MYD88, IFNA10]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CCNF, CDC20, CDC23, PSMD3, TRIM25, SKP2, CDC34, NEDD4L, ANAPC10, HACE1, PLK1, TGFB1I1, KIF14, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, DERL3, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMB8, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PTTG1, RNF43, PSMD14, CUL5, UBR1, CCNB1, WFS1, UBE2C, UBE2S, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, RNF6, USP18, AURKB, PSMB10, AURKA, ZNRF1, TBX21, RNF24, PML]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[FCN1, CLEC10A, ICAM2, ICAM3, PYCARD, IL18RAP, DHX58, PGLYRP1, PRKACB, ZBP1, MED1, LAG3, RSAD2, PRKCE, CD180, PRKCD, MUC3B, EREG, HLA-E, CLEC4A, CLEC4D, BTK, ADAM8, CLEC4E, S100A9, S100A8, CARD11, PRKDC, TXK, LY96, CD1D, DDX60, RASGRP1, KLRK1, CLEC7A, PLCG2, S100A14, CD14, CD300LF, MAP2K6, LYN, CAV1, SH2D1A, CRTAM, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, RIPK2, MMP2, IRAK3, PARP9, VAV1, MMP12, TLR1, HCK, PLSCR1, AIM2, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, LILRA2, HSPD1, RELB, PAK1, NRAS, CCL5, FYN, CARD9, NR1H4, TNIP3, F2RL1]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, RIPK2, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, BST2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, IGLL5, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, ZBP1, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, PSTPIP1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, AIM2, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, IGHV3-48, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, KDR, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, MET, CCL13, NOD2, EGFR, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, F2RL1, TEK]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, MAP3K8, EGR1, CHUK, IL1R1, RIPK2, IL1R2, IRAK3, NFKB1, NFKBIA, IL1A, IL1B, PLCB1, MYD88]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[RIPK2, NLRP3, TREM2, NOD2]
GO:0071225;cellular response to muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;334.57737126116905;8.16763571524637;0.011198003516026267;0.7686126355688037;[RIPK2, PTPN22, NOD2]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, TNFRSF9, LILRB1, IRAK3, ARRB2, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[CASP1, HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, IRF8, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, RPS6KB1, ZYX]
GO:0034516;response to vitamin B6;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;87.04156493882871;9.777073627680469;0.002913202846179917;0.8509193652572005;[KYNU]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, CKAP5, UXT, FES, NUP62, CDK1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, RIPK2, NOD2, PYCARD, NLRP12, AIM2, CASP1, TLR8, NLRP3, CCL19, TLR4]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, KPNA2, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGAV, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, PCSK5, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, AKR1C3, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, AIM2, IFNG, EHHADH, HSPD1]
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;662.774530299232;7.069023426578259;0.02218246707076338;0.7939391391080821;[KLF4, THBS1]
GO:0001550;ovarian cumulus expansion;3.0;1.0;0.6981203125901445;9.628524252492122;21.717098748465986;9.083926447120524;7.268517509911946E-4;0.6626727335416686;[EREG]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, CYBB, AZU1, TLR4, THBS1, CCR2]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, DDX58, RIPK2, STAT1, HSPD1, MMP12, IFIH1, IRF7, TLR8, TLR7, TLR4]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, NEDD4L, EGFR, PAK1, SFN, TGFB2, SYT2, FN1, IGF1, CXCL12, BCL2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, BRIP1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, SUV39H2, ALAS2, CDKN1B, SUV39H1, ADM, ALAD, CASP1, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL10, CXCL9, CXCL11, CXCR3, PIK3CD, DEFA1, CXCL16, CCR2]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0002636;positive regulation of germinal center formation;8.0;1.0;0.875;9.628524252492122;213.8757386662325;8.67846133901236;0.007158228497490581;0.8188169164668168;[TNFSF13B]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, CDKN1B, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, RNF6, PAK1, FRZB, SPP1, APBB1, SEMA4A, TGFB2, TGFB1, CDKN2C, CDKN2A, SEMA4B, INHBA, PML, BST2, BCL6, BCL2, SIPA1]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, IFIH1, DDX58, RIPK2, IRF7, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, RIPK2, SLC11A1, PDE4D, IL18, IL23A, IL1B, LTA, TLR8, IRF8, TLR7, TLR4, TXK, EBI3, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0014739;positive regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.65934785475751;9.777073627680469;0.003937952486160401;0.875;[AIF1]
GO:0019885;antigen processing and presentation of endogenous peptide antigen via MHC class I;5.0;0.8436909121759173;0.712086467948879;9.271849308553389;32.556158890958;7.8311634786251565;0.0010896253394395913;0.6907270763441554;[TAP1]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, RIPK2, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, KIF15, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, KIF23, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, OSBPL1A, HLA-DRB1]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, PGLYRP1, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0010499;proteasomal ubiquitin-independent protein catabolic process;8.0;1.0;0.875;9.628524252492122;190.80819184730524;6.518977089658987;0.006386178464905405;0.7083807915285978;[PSMB10, PSMB8, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, EGFR, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:1902043;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;424.7653704329427;6.943860283624253;0.014216514684375884;0.7703503496879909;[MAL, TIMP3, THBS1, ATF3]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, TGM2, FCER1G, IL15, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, EGFR, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, AIF1, PYCARD, CXCL10, CXCL12, CCL5, XCL2, XCL1, ADAM8, CCR2]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, TRIP13, BRCA2, EREG]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[CYFIP1, CSF3, CELSR1, F11R, CTGF, ICAM1, PYCARD, EPS8, ARHGDIA, STMN1, ARHGDIB, ARFIP1, PDGFRB, TMOD1, PDGFRA, MEF2C, PRKCE, TPM1, PRKCD, PFN1, EPHA3, CSF1R, TACSTD2, PDGFA, CORO1A, SPTA1, STAP1, NCKAP1L, VASP, TGFB1, VIL1, BST2, BST1, CXCL12, FES, JMY, ID1, NOX4, NRP1, PLEK, LMOD1, ARHGEF10L, ARHGAP6, CCR7, SPTAN1, EDN1, RHOG, RHOH, ARAP1, RHOC, SPTB, CIT, HCK, TMEFF2, HCLS1, RHOU, SHANK3, MET, LRP1, SYNPO2, CAPG, PAK1, NTF3, S1PR1, EPS8L1, FLNA, EPS8L3, JAM3, GSN, CCL21, DLC1, F2RL1, TEK]
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;7.8311634786251565;0.01635334542256394;0.8630410292508717;[NFKBIA, RIPK2, NOD2]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, PGLYRP1, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, IGKV4-1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, PBK, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL15, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, IGLV3-19, TLR2, C1QB, C1QA, PTGS2, EGFR, NT5E, IGKC, CCL18, IL33, CCL23, IGKV1-5, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, TGM2, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, SBNO2, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGLV2-23, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CASP1, CR2, CR1, GPX1, TNFRSF1B, LTA, XCL1, BIRC2, BIRC3, C1S, C1R, NLRC3, IGHV3-48, NOD2, USP18, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, IL2RA, TEK, FCGR2B]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, TNFRSF4, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CTSZ, IHH, PCSK6, PCSK5, CTSS, PLAU, CASP1, CTSH, CASP2, CTSG, PRSS3, MME, RIPK2, F3, ASPH, UQCRC1, PIK3C3, UQCRC2, ENPEP, C1R, HM13, CD5L, PSEN2, TMPRSS2, AEBP1, PERP, ACE, F11, DHCR24]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, DPYSL3, PLS1, ACTN1, PAWR, ACTN4, SORBS1, RHOC, MARCKS, ZYX, LCP1]
GO:0051151;negative regulation of smooth muscle cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;145.64858387880895;7.069023426578259;0.004874727027208368;0.7124295520356204;[DNMT1, EREG]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EGFR, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, SP3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, MET, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, NOG, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, RBL1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, S1PR1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, DNMT1, CALCRL, PTAFR, PTGS2, THBS1, AIF1, EGFR, GNAI2, PAK1, CCL5, PDGFD, S1PR1, HMOX1, ELANE, JUN, STAT1, IGF1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0071673;positive regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;372.1937940336002;8.67846133901236;0.012456991333636938;0.8400575416471059;[PDGFD, AIF1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, CDKN1B, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IL15, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, EGFR, IGFBP7, TGFB1, AGL, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0071672;negative regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;373.36881743152423;8.390779266560578;0.012496318309313052;0.8253454670833372;[AIF1]
GO:0002737;negative regulation of plasmacytoid dendritic cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;463.4470243338501;9.777073627680469;0.01551115482921088;0.896240625180289;[BST2]
GO:0071315;cellular response to morphine;8.0;1.0;0.875;9.628524252492122;528.974071528598;8.390779266560578;0.017704286128305307;0.8041048419030481;[AIF1]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[PTPRR, CUL5, EGF, GAB1, MATK, EGFR, EREG, BTC, HBEGF]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, CSF2, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL15, TNFRSF18, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, ITGA5, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, IGF1, GH1, CD4, IL6, CSPG4, CD24]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, PDE4D, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, NFKBID, LAT, HLA-DRB1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, CLSPN, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, PSMB10, USP1, IL33, USP9Y, PSMB8, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0031296;B cell costimulation;9.0;1.0;0.896240625180289;9.628524252492122;298.24063740046915;8.67846133901236;0.009981845734645991;0.8400575416471059;[CD320, TNFSF13B]
GO:0048305;immunoglobulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;133.331941423656;8.390779266560578;0.004462500088492957;0.8253454670833372;[CD40LG, TNFSF13B]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, CD40, PTGS2, PIK3C2A, THBS1, ETS1, KDR, AKT1, HMOX1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, RIPK2, PLK1, AZU1, CHI3L1, CALM3]
GO:0030511;positive regulation of transforming growth factor beta receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;345.4564576873422;6.518977089658987;0.011562116748168153;0.7083807915285978;[MYOCD, TGFB1I1, THBS1, TGFBR3, DAB2, LRG1, MEN1]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[CYFIP1, HACE1, RHOG, AIF1, EPS8, RAC2, RHOU]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[CSF2, IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, KDR, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, MET, HBEGF, TTK, EGFR, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, CSF3, PLXND1, LRRK2, ARRB1, MEN1, MEF2C, RIPK2, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[UNC93B1, TLR7, HAVCR2]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[STEAP4, FFAR2, MED1, GPX1, SIRT1, PLCB1, CEBPA, CEBPB, RETN, ADRB2, PTGS2, FOXO1, PRDM16, EGR2, LAMB3, NOC3L, KLF4, PSMB8, NR4A2, NR4A1, ALDH6A1, LRG1, NR4A3]
GO:1904417;positive regulation of xenophagy;9.0;1.0;0.896240625180289;9.628524252492122;536.7631489314033;7.9853141584524145;0.017964979539262647;0.8046099625986299;[RIPK2]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[CDKN1B, SLC8A1, CTGF, ICAM1, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, RPS6KB1, FKBP1B, NOX4]
GO:0097202;activation of cysteine-type endopeptidase activity;12.0;1.0;0.9481203125901445;9.628524252492122;669.1123145181327;7.212124270218933;0.0223945870049345;0.8169486831672182;[ASPH, RIPK2, PERP]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0019441;tryptophan catabolic process to kynurenine;10.0;1.0;0.9152410118609203;9.628524252492122;2139.3361475978627;8.16763571524637;0.07160165558256723;0.8329342821725234;[KYNU]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, IL33, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0019442;tryptophan catabolic process to acetyl-CoA;10.0;1.0;0.9152410118609203;9.628524252492122;2054.5202981753127;9.083926447120524;0.06876294543170325;0.8797934328124444;[KYNU]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, DPYSL3, ADCYAP1, MAP1B, S100A9, EPHA3, NEDD4L, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, APBB1, FKBP1B, CAMK1]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, AIF1, CCR2]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, RIPK2, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, TNIP3, S100A14, CD14, TLR4]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, DHFR, PKIA, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, STAT1, CENPF, LGR4, GMNN, CTGF, TNFRSF4, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, SP3, CIITA, LRRK2, FHL2, PIK3CD, FASLG, FOXM1, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, E2F8, PRRX1, EIF3E, IKZF1, UXT, KDR, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, BRIP1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H2, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, NEDD4L, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, CDKN1B, HAVCR2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, CDKN2A, NR1H2, NR1H4, POU4F1, FOSB, CSF2, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, DNMT1, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, CDK2, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, NOG, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, APBB1, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TIMELESS, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, RBL2, RBL1, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, MED1, ST14, CSTA, JAG1, ANXA1, AKR1C3, EREG, ADAM9, EPHA2]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, ICAM1, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, BRIP1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, FOSL1, BCL2, PLEKHF2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, IL15, AVPR1A, FOS, SIRT1, AES, PIK3C3, PTGS2, AIF1, FYN, NR1H4, AKR1C3, SIPA1, FOXA3, FOXA2]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CCNF, CDC20, CDC23, TRIM25, SKP2, CDC34, NEDD4L, ANAPC10, PLK1, KIF14, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, DERL3, PCNP, PSMB8, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PTTG1, PSMD14, UBR1, CCNB1, WFS1, UBE2C, UBE2S, CDK1, ARRB1, ARRB2, BIRC2, RNF6, AURKB, PSMB10, AURKA, ZNRF1, TBX21, RNF24, PML]
GO:0010748;negative regulation of plasma membrane long-chain fatty acid transport;9.0;1.0;0.896240625180289;9.628524252492122;652.3932031735304;8.390779266560578;0.02183501339445399;0.8253454670833372;[AKT1, THBS1]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, RIPK2, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, ICAM1, RUVBL2, CHEK2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, PRKDC, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, BRIP1, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, CDK4, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, EGFR, P2RY6, PAK1, SPP1, FYN, CSK, STAT1, AKR1C3, SORBS1, POU4F1, TSHR, RPS6KB1, FOSB, RAMP1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, SIGLEC16, CARD9, LILRB2, MAPK13, IL6, F2RL1, MYD88, IL17A]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[CD180, LY86, LY96, MIF]
GO:0052548;regulation of endopeptidase activity;8.0;0.657518819034173;0.7037594095170865;8.935377071932177;60.84394611095035;3.7831122003739;0.0020363921203370686;0.5684685338598301;[SERPINE1, SPINT2, AQP1, RPS6KA1, AKT1, SOX7, DAPK1, POR, SFRP2, SPINT1, SLPI, IFI27, SERPING1, NAIP, C3, SFN, A2M, LYN, TNFSF14, BST2, CD27, SERPINA1, TIMP2, CTSH, TIMP3, TIMP1, SERPINB2, RIPK2, SERPINB9, SIRT1, F3, PAX2, PSMA3, SERPINB10, CSTA, IFI6, PTGS2, CST7, CST3, PERP, CASP8AP2, GSN, PSMB8, FABP1, NLRP12, DLC1, PROS1, TNF, CTGF, PYCARD, PTTG1, LAMP3, APLP2, F2R, S100A9, S100A8, PSMD14, NLRP3, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, TNFAIP8, FASLG, ARRB1, ARRB2, CYR61, CASP1, CR1, GPX1, PLAUR, TNFRSF1B, MMP9, AIM2, ASPH, LCK, COL6A3, BIRC5, BIRC2, LTF, BIRC3, LEF1, NLRC4, THBS1, HSPD1, SPOCK2, SPOCK3, FYN, SNCA, HSPE1, KLF4, PML, P2RX1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, DPYSL3, CYP1B1, HOXA7, MEF2C, IGFBP5, CD300A, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, RRAS, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, BST2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, NOG, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, KDR, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, KIF20B, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, EGFR, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, SYNE2, ITGAV, ITGA4, TNFRSF18, MMP9, FGR, IFNG, XCL2, XCL1, ITGA5, MET, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, S1PR1, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0034134;toll-like receptor 2 signaling pathway;12.0;0.9326813400603323;0.9144609826203107;9.590783924509275;412.6549923027037;8.16763571524637;0.013811191226989502;0.8658135829017477;[RIPK2, TLR2]
GO:0009299;mRNA transcription;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;700.7520401355927;6.558197802812269;0.023453540147446512;0.7506275524841266;[MED1, C5AR1, LMO2, EREG, FLNA]
GO:1903588;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;10.0;1.0;0.9152410118609203;9.628524252492122;357.96927251473664;8.390779266560578;0.011980909399638815;0.8443458537639685;[THBS1]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, BST2, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK2, SPOCK3, SNCA, KLF4, FABP1]
GO:0070427;nucleotide-binding oligomerization domain containing 1 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;9.083926447120524;0.01635334542256394;0.9271073857191605;[NFKBIA, RIPK2]
GO:0032743;positive regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.409777797693995;0.002183412136085803;0.6509166472493662;[CD86, CD83, CD80, CD3E, PDE4B, CCR2, ANXA1, RIPK2, PDE4D, IL1A, CD4, IL1B, CD28, PRKCQ, CARD11]
GO:0051918;negative regulation of fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;332.9628274369728;7.474488534686424;0.011143966187225523;0.7784863164434164;[THBD, SERPINE1, THBS1]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, CCND2, PLCB1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, RIPK2, MAPK14, HLA-G, CD40LG, IFNG, IL23A, IRF8, LTB, PLCB1, TLR4, TLR2]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CDKN1B, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, EGFR, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF2, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, TXNDC5, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, ITGAV, GPX1, TNFRSF18, TNFRSF1B, ADAMTS20, BIRC5, ITGA5, MET, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, KDR, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, NOG, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, CCND2, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[CD151, EBI3, FYN, TNFRSF4, TNFSF14, RIPK2, IL15, SLC11A1, LILRB1, IL23A, FKBP1B, DOCK2]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, CDKN2A, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, CDK4, BCL2, MAP3K11, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, CHEK2, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, AKR1C3, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP1, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
